Targeted Inhibition of mTOR Signaling Improves Sensitivity of Esophageal Squamous Cell Carcinoma Cells to Cisplatin
Figure 1
Expression of mTOR in human normal esophageal and ESCC tissues by immunohistochemical analysis. (a) Negative expression of mTOR in normal tissues of the esophagus. (b) Moderate positive expression of mTOR in dysplasia tissues. (c) Positive expression of mTOR in ESCC tissues (×400).
